- Home
- WLDS vs KTTA Comparison
WLDS vs KTTA Comparison
Compare WLDS & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WLDS
- KTTA
- Stock Information
- Founded
- WLDS 2014
- KTTA 2020
- Country
- WLDS Israel
- KTTA United States
- Employees
- WLDS N/A
- KTTA 4
- Industry
- WLDS Computer Communications Equipment
- KTTA Biotechnology: Pharmaceutical Preparations
- Sector
- WLDS Telecommunications
- KTTA Health Care
- Exchange
- WLDS Nasdaq
- KTTA Nasdaq
- Market Cap
- WLDS 2.4M
- KTTA 5.5M
- IPO Year
- WLDS 2022
- KTTA 2021
- Fundamental
- Price
- WLDS $5.55
- KTTA $0.72
- Analyst Decision
- WLDS
- KTTA
- Analyst Count
- WLDS 0
- KTTA 0
- Target Price
- WLDS N/A
- KTTA N/A
- AVG Volume (30 Days)
- WLDS 23.2M
- KTTA 201.4K
- Earning Date
- WLDS 09-09-2025
- KTTA 11-12-2025
- Dividend Yield
- WLDS N/A
- KTTA N/A
- EPS Growth
- WLDS N/A
- KTTA N/A
- EPS
- WLDS N/A
- KTTA N/A
- Revenue
- WLDS $422,000.00
- KTTA N/A
- Revenue This Year
- WLDS N/A
- KTTA N/A
- Revenue Next Year
- WLDS N/A
- KTTA N/A
- P/E Ratio
- WLDS N/A
- KTTA N/A
- Revenue Growth
- WLDS N/A
- KTTA N/A
- 52 Week Low
- WLDS $1.00
- KTTA $0.65
- 52 Week High
- WLDS $25.44
- KTTA $7.50
- Technical
- Relative Strength Index (RSI)
- WLDS 62.80
- KTTA 43.23
- Support Level
- WLDS $1.00
- KTTA $0.74
- Resistance Level
- WLDS $11.40
- KTTA $0.81
- Average True Range (ATR)
- WLDS 1.22
- KTTA 0.06
- MACD
- WLDS 0.54
- KTTA -0.01
- Stochastic Oscillator
- WLDS 43.75
- KTTA 9.32
About WLDS Wearable Devices Ltd.
Wearable Devices Ltd develops and sells human-machine interface solutions for the smart wearables industry. These digital devices include consumer electronics, smart watches, smartphones, AR glasses, VR headsets, televisions, PCs, laptop computers, drones, robots, etc. The company has completed the transition phase from research and development to commercialization of technology into B2B and B2C products. Its products include Mudra Inspire, a band for the Apple Watch that allows touchless operation and control of Apple ecosystem devices such as iPhone, Mac computer, Apple TV, and iPad, inter alia.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).